Latest debt-to-equity ratio

Telomir Pharmaceuticals Debt-to-equity ratio

Direct answer

Telomir Pharmaceuticals's debt-to-equity ratio is 2.72%.

The verified market snapshot reports 2.72%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 5, 2026.

Get free Telomir Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
2.72%

Explore related company data

View Telomir Pharmaceuticals's market capitalizationView Telomir Pharmaceuticals's price-to-book ratioView Telomir Pharmaceuticals's return on equityView Telomir Pharmaceuticals's dividend yieldView Telomir Pharmaceuticals's 52-week price rangeView Telomir Pharmaceuticals's profit marginView all Telomir Pharmaceuticals key metricsReturn to Telomir Pharmaceuticals profile